My Account
About Us
Contact us
الواجهة العربية
Medical News Medical News
Aricles Articles
Events Events
Guidelines Guidelines
Videos Library Videos Library
Diseases Diseases
Follow us : facebook twitter Digg Linkedin Boxiz

Please select the categories you are intersted in:
News Articles Guidelines Events Videos Journals' abstracts

Latest Subscribers
Advanced Search »



You must sign in to use this servcie

Feedback - Please use the form below to send your query or comment

You must sign in to use this servcie




this medicine is for the control of vestibular disorders such as vertigo, tinnitus, nausea and vomiting such as is seen in Meniere’s Disease. this medicine is also effective in the control of motion sickness


this medicine should not be given to patients with known hypersensitivity to cinnarizine.

Adverse reactions:

For all indications: Drowsiness and gastro-intestinal disturbances may occur. These are usually transient. In rare cases, headache, dry mouth, perspiration or allergic reactions may occur. For long term treatment, i.e. vestibular symptoms: Rare cases of weight gain and very rare cases of lichen planus, lupus-like skin reactions and cholestatic jaundice have been reported. Rare cases of aggravation or appearance of extrapyramidal symptoms (sometimes associated with depressive feelings) have been described, predominantly in elderly people during prolonged therapy. The treatment should be discontinued in such cases


Concurrent use of alcohol, CNS depressants or tricyclic antidepressants may potentiate the sedative effects of either these drugs or of this medicine.


As with other antihistamines, this medicine may cause epigastric discomfort; taking it after meals may diminish the gastric irritation. In patients with Parkinson’s Disease, this medicine should only be given if the advantages outweigh the possible risk of aggravating this disease. Because of its antihistamine effect, this medicine may prevent an otherwise positive reaction to dermal reactivity indicators if used within 4 days prior to testing. Use of cinnarizine should be avoided in porphyria. There have been no specific studies in hepatic or renal dysfunction. this medicine should be used with care in patients with hepatic or renal insufficiency. Patients with rare hereditary problems of fructose or galactose intolerance, Lapp lactase deficiency, glucose-galactose malabsorption or sucrase-isomaltase insufficiency, should not take this medicine because it contains lactose andh



Dosage and Administration

You must sign in to use this servcie

Technical Description

You must sign in to use this servcie

Forgot your password

sign up

Consultants Corner

Dr. Faisal Dibsi

Dr. Faisal Dibsi Specialist of Otolaryngology - Head and Neck Surgery

Yaser Habrawi , F.R.C.S.Ed

Yaser Habrawi , F.R.C.S.Ed Consultant Ophthalmologist

Dr. Hani Najjar

Dr. Hani Najjar Pediatrics, Neurology

Dr. Tahsin Martini

Dr. Tahsin Martini Degree status: M.D. in Ophthalmology

Dr . Dirar Abboud

Dr . Dirar Abboud Hepatologist – Gastroenterologist

Dr. Samer Al-Jneidy

Dr. Samer Al-Jneidy Pediatrician

Dr. Talal Sabouni


Samir Moussa M.D.

Samir Moussa M.D. ENT Specialist

Which of the following you are mostly interested in?

Cancer Research
Mental Health
Heart Disease & Diabetes
Sexual Health
Obesity and Healthy Diets
Mother & Child Health

Disclaimer : This site does not endorse or recommend any medical treatment, pharmaceuticals or brand names. More Details